norvixpro[.]com

Analysis of norvixpro.com indicates that the domain was registered on 14 January 2026 through Realtime Register B.V. and immediately pointed to the Cloudflare address 172.67.207.31, which is associated with ASN 13335 in the United States. The site returned the HTTP title “NorvixPro” and presented a TLS certificate identified as “WE1”. Security telemetry shows that the domain is classified as a brand‑impersonation campaign targeting the brand argent. The same classification appears in three independent blocklists and the domain is actively blocked by PhishDestroy, MetaMask, and SEAL. VirusTotal scans recorded 12 positive detections out of 93 participating scanners, confirming malicious intent.

AlienVault OTX lists the domain in a single threat‑intelligence pulse, further corroborating its suspicious nature. Gridinsoft assigned a trust score of zero out of one hundred, indicating a complete lack of reputation. Current infrastructure status is offline, but the historical footprint suggests that the domain was operational before being taken down. Defenders should treat any traffic to norvixpro.com as hostile. The IP address 172.67.207.31 is shared by many legitimate Cloudflare customers, so simple IP‑based blocking may generate false positives; instead, rule sets should target the fully qualified domain name and correlate with the observed blocklist identifiers.

The low trust score and multiple vendor detections warrant inclusion in allow‑list exemptions for legitimate services and proactive blocking for internal users. Continuous monitoring of the domain’s DNS records is recommended, as re‑activation on a different host could occur. Security teams should also flag any communications that reference the brand argent and reference the page title “NorvixPro” as potential phishing vectors. Integration of the observed blocklist entries and OTX pulse into SIEM correlation rules will improve detection of related campaigns.